fda covid vaccine - Search News

Order byBest matchMost fresh

FDA, COVID

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

· 3h · on MSN

· 4h · on MSN

FDA sets new COVID booster guidelines for healthy adults under 65

· 13h · on MSN

FDA sets new requirements for COVID vaccines in healthy adults and children

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

· 11h

· 13h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 14h

US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved

FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 9h

· 7h

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 7h

F.D.A. Poised to Restrict Access to Covid Vaccines

13hon MSN

FDA to limit future Covid-19 shots to older people and those at risk of serious infection

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.

12hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk," the agency said in an article published by The New England Journal of Medicine, authored by FDA Commissioner Dr. Martin Makary and his new top vaccines official, Dr. Vinay Prasad.

9hon MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

FDA offers new guidelines to shift COVID vaccine focus to high-risk groups

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over the age of 65 years and for all persons above the age of 6 months with

14hon MSN

FDA to limit covid shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

Explore more

United States

Food and Drug Administration

Novavax